Literature DB >> 1629699

Nucleotide sequence and coding strategy of the Uukuniemi virus L RNA segment.

R M Elliott1, E Dunn, J F Simons, R F Pettersson.   

Abstract

The complete nucleotide sequence of the L RNA segment of Uukuniemi virus has been determined from cloned cDNA. The L RNA is 6423 nucleotides in length, and is of negative polarity. The viral-complementary RNA contains a single large open reading frame of 2104 codons which corresponds to the L protein (M(r) 241039). Comparison with the L protein sequences of other members of the Bunyaviridae showed homology with the Rift Valley fever phlebovirus L protein (38% amino acid identity), but no detectable similarity with bunyavirus, hantavirus or tospovirus L proteins. These data lend further support for the recent reclassification of uukuviruses and phleboviruses into the same genus, Phlebovirus, in the family Bunyaviridae. The L RNA sequence completes the determination of the Uukuniemi virus genome: since the M RNA segment is 3229 and the S RNA segment 1720 nucleotides, the whole genome comprises 11372 nucleotides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629699     DOI: 10.1099/0022-1317-73-7-1745

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs.

Authors:  R Flick; R F Pettersson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases.

Authors:  Jeremy A Bruenn
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

3.  Characterization of the Candiru antigenic complex (Bunyaviridae: Phlebovirus), a highly diverse and reassorting group of viruses affecting humans in tropical America.

Authors:  Gustavo Palacios; Robert Tesh; Amelia Travassos da Rosa; Nazir Savji; Wilson Sze; Komal Jain; Robert Serge; Hilda Guzman; Carolina Guevara; Marcio R T Nunes; Joaquim P Nunes-Neto; Tadeusz Kochel; Stephen Hutchison; Pedro F C Vasconcelos; W Ian Lipkin
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  Complete genetic characterization and analysis of isolation of Sin Nombre virus.

Authors:  V E Chizhikov; C F Spiropoulou; S P Morzunov; M C Monroe; C J Peters; S T Nichol
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules.

Authors:  N Lopez; R Muller; C Prehaud; M Bouloy
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Generation and analysis of infectious virus-like particles of uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding.

Authors:  Anna K Overby; Vsevolod Popov; Etienne P A Neve; Ralf F Pettersson
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

7.  Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments.

Authors:  Kirsten Flick; Anna Katz; Anna Overby; Heinz Feldmann; Ralf F Pettersson; Ramon Flick
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance.

Authors:  Ramon Flick; Fredrik Elgh; Ralf F Pettersson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Uukuniemi Virus as a Tick-Borne Virus Model.

Authors:  Magalie Mazelier; Ronan Nicolas Rouxel; Michael Zumstein; Roberta Mancini; Lesley Bell-Sakyi; Pierre-Yves Lozach
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  The membrane glycoprotein G1 of Uukuniemi virus contains a signal for localization to the Golgi complex.

Authors:  L Melin; R Persson; A Andersson; A Bergström; R Rönnholm; R F Pettersson
Journal:  Virus Res       Date:  1995-04       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.